HomeCompareBEXFX vs JNJ

BEXFX vs JNJ: Dividend Comparison 2026

BEXFX yields 1.78% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BEXFX wins by $2.3K in total portfolio value
10 years
BEXFX
BEXFX
● Live price
1.78%
Share price
$19.09
Annual div
$0.34
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.3K
Annual income
$200.19
Full BEXFX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BEXFX vs JNJ

📍 BEXFX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBEXFXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BEXFX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BEXFX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BEXFX
Annual income on $10K today (after 15% tax)
$151.61/yr
After 10yr DRIP, annual income (after tax)
$170.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $533.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BEXFX + JNJ for your $10,000?

BEXFX: 50%JNJ: 50%
100% JNJ50/50100% BEXFX
Portfolio after 10yr
$21.1K
Annual income
$513.99/yr
Blended yield
2.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BEXFX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BEXFX buys
0
JNJ buys
0
No recent congressional trades found for BEXFX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBEXFXJNJ
Forward yield1.78%3.36%
Annual dividend / share$0.34$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$22.3K$20.0K
Annual income after 10y$200.19$827.78
Total dividends collected$1.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BEXFX vs JNJ ($10,000, DRIP)

YearBEXFX PortfolioBEXFX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,878$178.37$10,676$355.77+$202.00BEXFX
2$11,821$181.34$11,407$389.39+$414.00BEXFX
3$12,833$184.16$12,198$426.53+$635.00BEXFX
4$13,918$186.85$13,056$467.62+$862.00BEXFX
5$15,082$189.39$13,987$513.12+$1.1KBEXFX
6$16,329$191.80$14,998$563.56+$1.3KBEXFX
7$17,666$194.08$16,098$619.52+$1.6KBEXFX
8$19,099$196.23$17,295$681.69+$1.8KBEXFX
9$20,634$198.27$18,599$750.82+$2.0KBEXFX
10$22,279$200.19$20,022$827.78+$2.3KBEXFX

BEXFX vs JNJ: Complete Analysis 2026

BEXFXStock

The fund normally invests 80% of its net assets in equity securities in the form of common stock of growth companies domiciled, headquartered or whose primary business activities or principal trading markets are in developing countries. A developing country is a country included in the MSCI Emerging Markets (EM) Index and other countries determined by the Adviser to be developing countries based on classifications made by the International Monetary Fund or on country characteristics similar to those of the countries in the EM index.

Full BEXFX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BEXFX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BEXFX vs SCHDBEXFX vs JEPIBEXFX vs OBEXFX vs KOBEXFX vs MAINBEXFX vs ABBVBEXFX vs MRKBEXFX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.